Reversal of estrogen‐resistance in murine mammary adenocarcinomas María Fernanda MontecchiaAlfredo MolinoloClaudia Lanari OriginalPaper Pages: 93 - 99
The additionally glycosylated variant of human sex hormone‐binding globulin (SHBG) is linked to estrogen‐dependence of breast cancer Marzia BecchisRoberto FrairiaNicoletta Fortunati OriginalPaper Pages: 101 - 107
Quality of life in patients with ductal carcinoma in situ of the breast treated with conservative surgery and postoperative irradiation Maurizio AmichettiOrazio CaffoNazario Teodorani OriginalPaper Pages: 109 - 115
Randomized trial of diethylstilbestrol vs. tamoxifen in postmenopausal women with metastatic breast cancer. An updated analysis Prema P. PeethambaramJames N. IngleCharles L. Loprinzi OriginalPaper Pages: 117 - 122
Vitamin D3 receptor (VDR) expression in HC‐11 mammary cells: regulation by growth‐modulatory agents, differentiation, and Ha‐ras transformation Maria Teresa F. EscaleiraM. Mitzi Brentani OriginalPaper Pages: 123 - 134
De‐regulation of GRP stress protein expression in human breast cancer cell lines Gadi GazitJun LuAmy S. Lee OriginalPaper Pages: 135 - 146
Invasion marker PAI‐1 remains a strong prognostic factor after long‐term follow‐up both for primary breast cancer and following first relapse Nadia HarbeckChristoph ThomssenManfred Schmitt OriginalPaper Pages: 147 - 157
Tumour necrosis factor‐α and interleukin‐1 and ‐6 in fibrocystic breast disease Alfonso HerruzoJose Antonio CastillaSalomón Menjón OriginalPaper Pages: 159 - 164
Dose intensification of mitoxantrone in combination with paclitaxel in advanced breast cancer: a phase II study Francesco Di CostanzoAndrea SdroboliniLucio Giustini OriginalPaper Pages: 165 - 171
Constitutive activation of pp125fak in newly isolated human breast cancer cell lines Kathleen M. Woods IgnatoskiStephen P. Ethier OriginalPaper Pages: 173 - 182
